Dr. Michael Krohn, born in 1963, studied biology and
graduated in molecular biology with a PhD from the Heinrich-Heine
University (HHU) Duesseldorf, Germany, and did his postdoctoral training
at the Max-Planck Institute for Immunology in Freiburg with focus on
molecular and cell biology.
Dr. Michael Krohn started his
industrial career at BRAIN AG as a project manager in 1997. In 2001 he
took over the management of the BioActives & Performance Biologicals
technology unit. In this position he was responsible for the research
and development of bioactive ingredients mainly for the food and
cosmetic industries for industrial applications and products. In
addition, his responsibilities included contract research in cooperation
with national and international partners, the development of
proprietary technologies as well as business development on a national
and international level in the field of functional ingredients for B2B
markets. Furthermore, Dr. Krohn was responsible for the implementation
and overall coordination of the strategic industrial alliance “Natural
Life Excellence Network 2020” (NatLifE 2020), initiated by the German
Federal Ministry of Education and Research (BMBF).
In 2013 Dr.
Michael Krohn became member of the executive committee at BRAIN and has
meanwhile 20 years’ professional experience in Industrial Biotechnology.
In March 2019, he took over the position as Head of Research &
Development and is thus responsible for the entire research and
development division of BRAIN AG.